Skip to main content

Nasdaq IPOs

Mortgage lender Alpha Investment files for a $15 million IPO

6 years 7 months ago
Alpha Investment, a mortgage lender backed by Omega Commercial Finance, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. The Columbus, OH-based company was founded in 2013 as Gogo Baby and plans to list on the Nasdaq under the symbol ALPC.
Renaissance Capital

Mortgage lender Alpha Investment files for a $15 million IPO

6 years 7 months ago
Alpha Investment, a mortgage lender backed by Omega Commercial Finance Corp, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. The Columbus, OH-based company was founded in 2013 and plans to list on the Nasdaq under the symbol ALPC. Aegis Ca
Renaissance Capital

SPAC Flying Eagle Acquisition files for a $500 million IPO

6 years 7 months ago
Flying Eagle Acquisition, the sixth blank check company formed by SPAC veterans Jeff Sagansky and former MGM CEO Harry Sloan, filed with the SEC on Tuesday for an initial public offering. The Los Angeles, CA-based company plans to raise $500 million by offering 50 million units
Renaissance Capital

SPAC Flying Eagle Acquisition files for a $500 million IPO

6 years 7 months ago
Flying Eagle Acquisition, the sixth blank check company formed by SPAC veterans Jeff Sagansky and former MGM CEO Harry Sloan, filed with the SEC on Tuesday for an initial public offering. The Los Angeles, CA-based company plans to raise $500 million by offering 50 million units
Renaissance Capital

Cannabis SPAC Greenrose Acquisition prices $150 million IPO at $10

6 years 7 months ago
Greenrose Acquisition, a blank check company targeting the cannabis industry, raised $150 million by offering 15 million units at $10 to command a market value of $191 million. Each unit consists of one share of common stock and one warrant to purchase a share of common
Renaissance Capital

US IPO Week Ahead: IPO market hits February lull in 2-IPO week

6 years 7 months ago
Just a biotech and a Chinese issuer are expected to IPO in the week ahead as the market prepares for the February lull. Early-stage oncology biotech Revolution Medicines (RVMD) is expected to raise $150 million at an $850 million market cap. Backed by
Renaissance Capital
Checked
21 minutes 43 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed